Fluid resuscitation with 6% hydroxyethyl starch (130/0.4) in acutely Ill patients: An updated systematic review and meta-analysis

Anesthesia and Analgesia

Volumn 114, Issue 1, 2012, Pages 159-169

  Gattas, David J ^a,b   Dan, Arina ^a,c   Myburgh, John ^a,d   Billot, Laurent ^a   Lo, Serigne ^a   Finfer, Simon ^a,e  

^a GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c LIVERPOOL HOSPITAL   (Australia)

^d ST GEORGE HOSPITAL   (Australia)

^e ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GELATIN; HETASTARCH; POLYGELINE; RINGER LACTATE SOLUTION; SODIUM CHLORIDE;

ACUTE KIDNEY FAILURE; BLEEDING; COLLOID; COMPARATIVE EFFECTIVENESS; CRITICALLY ILL PATIENT; CRYSTALLOID; ERYTHROCYTE TRANSFUSION; FLUID RESUSCITATION; HUMAN; INTERMETHOD COMPARISON; MORTALITY; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SENSITIVITY ANALYSIS; SURGICAL PATIENT; SYSTEMATIC REVIEW;

ACUTE KIDNEY INJURY; CRITICAL ILLNESS; EVIDENCE-BASED MEDICINE; FLUID THERAPY; HETASTARCH; HOSPITAL MORTALITY; HUMANS; PLASMA SUBSTITUTES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESUSCITATION; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84555191910     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e318236b4d6     Document Type: Review

References (65)

1. Finfer S, Liu B, Taylor C, Bellomo R, Billot L, Cook D, Du B, McArthur C, Myburgh J. Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care 2010;14:R185
2. Miletin MS, Stewart TE, Norton PG. Influences on physicians' choices of intravenous colloids. Intensive Care Med 2002;28: 917-24 (Pubitemid 34762227)
3. Bunn F, Trivedi D, Ashraf S. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev 2008;1:CD001319
4. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2011;3:CD000567
5. Dart AB, Mutter TC, Ruth CA, Taback SP. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 2010;1:CD007594
6. Zarychanski R, Turgeon AF, Fergusson DA, Cook DJ, Hébert PC, Bagshaw SM, Monsour D, McIntyre L. Renal outcomes and mortality following hydroxyethyl starch resuscitation of critically ill patients: systematic review and meta-analysis of randomized trials. Open Med 2009;3:E196-209
7. Hartog CS, Kohl M, Reinhart K. A systematic review of third-generation hydroxyethyl starch (HES 130/0.4) in resuscitation: safety not adequately addressed. Anesth Analg 2011;112:635-45
8. Boldt J, Suttner S, Brosch C, Lehmann A, Rohm K, Mengistu A. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy. Anesth Analg 2009;109:1752-62
9. The Crystalloid versus Hydroxyethyl Starch Trial Management Committee. The Crystalloid versus Hydroxyethyl Starch Trial: protocol for a multi-centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Med 2011;37:816-23
10. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs-the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-12
11. Juni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001;323:42-6 (Pubitemid 32682008)
12. Higgins JPT, Deeks JJ, Altman DG, on behalf of the Cochrane Statistical Methods Group, eds. 16.9.2: Studies with zero-cell counts. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0, updated March 2011. The Cochrane Collaboration, 2011. Available at: www.cochrane-handbook.org
13. Ratajczak J, Szczepanik AB, Meissner AJ, Ostas A, Wiszniewski A, Bilski R. Small volume resuscitation for acute intraoperative haemorrhage: comparison of 7.5% saline and 6% hydroxyethyl starch [in Polish]. Anestezjol Intens Ter 2009;41:6-10
14. Potapov OL. Advantages of application of hydroxyethylstarch of the III generation during the operations with epidural anesthesia [in Ukrainian]. Klin Khir 2010:47-50
15. Sudhakar GV, Lakshmi P. Role of HES 130/0.4 in resuscitation of patients with major burn injury. Transfus Altern Transfus Med 2008;10:43-50
16. Zhao Y. Study to Evaluate the Effect of Hydroxyethyl Starch (HES) in Complications of Patients After Abdominal Surgery. ClinicalTrials.gov identifier NCT00308126. Accessed February 27, 2011
17. Boldt J, Ducke M, Kumle B, Papsdorf M, Zurmeyer EL. Influence of different volume replacement strategies on inflammation and endothelial activation in the elderly undergoing major abdominal surgery. Intensive Care Med 2004;30:416-22 (Pubitemid 38375615)
18. Boldt J, Haisch G, Suttner S, Kumle B, Schellhaass A. Effects of a new modified, balanced hydroxyethyl starch preparation (Hextend) on measures of coagulation. Br J Anaesth 2002;89:722-8 (Pubitemid 35277221)
19. Lang K, Boldt J, Suttner S, Haisch G. Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery. Anesth Analg 2001;93:405-9 (Pubitemid 32701540)
20. Lang K, Suttner S, Boldt J, Kumle B, Nagel D. Volume replacement with HES 130/0.4 may reduce the inflammatory response in patients undergoing major abdominal surgery. Can J Anaesth 2003;50:1009-16 (Pubitemid 38139563)
21. Boldt J, Brosch C, Rohm K, Papsdorf M, Mengistu A. Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients. Br J Anaesth 2008;100:457-64 (Pubitemid 351773609)
22. Boldt J, Brosch C, Ducke M, Papsdorf M, Lehmann A. Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin. Crit Care Med 2007;35:2740-6 (Pubitemid 350175770)
23. Boldt J, Scholhorn T, Mayer J, Piper S, Suttner S. The value of an albumin-based intravascular volume replacement strategy in elderly patients undergoing major abdominal surgery [erratum appears in Anesth Analg 2007;104:317]. Anesth Analg 2006;103:191-9 (Pubitemid 44036058)
24. Boldt J, Brosch C, Rohm K, Lehmann A, Mengistu A, Suttner S. Is albumin administration in hypoalbuminemic elderly cardiac surgery patients of benefit with regard to inflammation, endo-thelial activation, and long-term kidney function? Anesth Analg 2008;107:1496-503
25. Haisch G, Boldt J, Krebs C, Suttner S, Lehmann A, Isgro F. Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. J Cardio-thorac Vasc Anesth 2001;15:316-21 (Pubitemid 32553378)
26. Haisch G, Boldt J, Krebs C, Kumle B, Suttner S, Schulz A. The influence of intravascular volume therapy with a new hy-droxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery. Anesth Analg 2001;92:565-71 (Pubitemid 32185091)
27. Boldt J, Brenner T, Lehmann A, Lang J, Kumle B, Werling C. Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: comparison of a new starch preparation with gelatin. Intensive Care Med 2003;29:763-9 (Pubitemid 36609569)
28. Dubin A, Pozo MO, Casabella CA, Murias G, Palizas F, Moseinco MC, Kanoore Edul VS, Estenssoro E, Ince C. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal-directed therapy of septic patients. J Crit Care 2010;25:659
29. Dolecek M, Svoboda P, Kantorova I, Scheer P, Sas I, Bibrova J, Radvanova J, Radvan M. Therapeutic influence of 20% albumin versus 6% hydroxyethylstarch on extravascular lung water in septic patients: a randomized controlled trial. Hepa-togastroenterology 2009;56:1622-8
30. Palumbo D, Servillo G, D'Amato L, Volpe ML, Capogrosso G, De Robertis E, Piazza O, Tufano R. The effects of hydroxyethyl starch solution in critically ill patients. Minerva Anestesiol 2006;72:655-64 (Pubitemid 44251571)
31. Neff TA, Doelberg M, Jungheinrich C, Sauerland A, Spahn DR, Stocker R. Repetitive large-dose infusion of the novel hydroxy-ethyl starch 130/0.4 in patients with severe head injury. Anesth Analg 2003;96:1453-9 (Pubitemid 36512891)
32. Gondos T, Marjanek Z, Ulakcsai Z, Szabo Z, Bogar L, Karolyi M, Gartner B, Kiss K, Havas A, Futo J. Short-term effectiveness of different volume replacement therapies in postoperative hypovolaemic patients. Eur J Anaesthesiol 2010;27:794-800
33. Inal MT, Memis D, Karamanlioglu B, Sut N. Effects of polyge-line and hydroxyethyl starch solutions on liver functions assessed with LIMON in hypovolemic patients. J Crit Care 2010;25:361.e1-5
34. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0, updated March 2011. The Cochrane Collaboration, 2011. Available at: www.cochrane-handbook.org
35. Myburgh JA. Fraud in fluid resuscitation research. Med J Aust 2011;194:621-2
36. Wiedermann CJ, Dunzendorfer S, Gaioni LU, Zaraca F, Joannidis M. Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials. Crit Care 2010;14:R191
37. Kozek-Langenecker SA, Jungheinrich C, Sauermann W, Van der Linden P. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials. Anesth Analg 2008;107:382-90
38. Wilkes MM, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a metaanalysis of postoperative bleeding. Ann Thorac Surg 2001;72:527-33
39. Akech S, Ledermann H, Maitland K. Choice of fluids for resuscitation in children with severe infection and shock: systematic review. BMJ 2010;341:c4416
40. Youssef MA, Al-Inany HG, Evers JL, Aboulghar M. Intra-venous fluids for the prevention of severe ovarian hyperstimulation syndrome. Cochrane Database Syst Rev 2011;2:CD001302
41. Asplund K. Haemodilution for acute ischaemic stroke. Cochrane Database Syst Rev 2002;4:CD000103
42. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-39
43. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001;357:911-6 (Pubitemid 32247279)
44. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004;350:2247-56 (Pubitemid 38669207)
45. Myburgh J. CHEST and the impact of fraud in fluid resuscitation research. Crit Care Resusc 2011;13:69-70
46. Mittermayr M, Streif W, Haas T, Fries D, Velik-Salchner C, Klingler A, Oswald E, Bach C, Schnapka-Koepf M, Innerhofer P. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg 2007;105:905-17 (Pubitemid 47479300)
47. Schramko A, Suojaranta-Ylinen R, Kuitunen A, Raivio P, Kukkonen S, Niemi T. Hydroxyethylstarch and gelatin solutions impair blood coagulation after cardiac surgery: A prospective randomized trial. Br J Anaesth 2010;104:691-7
48. Volta CA, Alvisi V, Campi M, Marangoni E, Alvisi R, Castel-lazzi M, Fainardi E, Manfrinato MC, Dallocchio F, Bellini T. Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study. Anesthesiology 2007;106:85-91 (Pubitemid 46035407)
49. Van der Linden PJ, De Hert SG, Deraedt D, Cromheecke S, De Decker K, De Paep R, Rodrigus I, Daper A, Trenchant A. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs. Anesth Analg 2005;101:629-34 (Pubitemid 41208482)
50. Ooi JSM, Ramzisham ARM, Zamrin MD. Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery? Asian Cardiovasc Thorac Ann 2009;17:368-72
51. Godet G, Lehot JJ, Janvier G, Steib A, De Castro V, Coriat P. Safety of HES 130/0.4 (Voluven®) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial [erratum appears in Eur J Anaesthesiol 2008;25:1042]. Eur J Anaesthesiol 2008;25:986-94
52. Mahmood A, Gosling P, Vohra RK. Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgery. Br J Surg 2007;94:427-33 (Pubitemid 46624720)
53. Schramko AA, Suojaranta-Ylinen RT, Kuitunen AH, Kukkonen SI, Niemi TT. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Anesth Analg 2009;108:30-6
54. Mukhtar A, Aboulfetouh F, Obayah G, Salah M, Emam M, Khater Y, Akram R, Hoballah A, Bahaa M, Elmeteini M, Hamza A. The safety of modern hydroxyethyl starch in living donor liver transplantation: a comparison with human albumin. Anesth Analg 2009;109:924-30
55. Kasper SM, Meinert P, Kampe S, Gorg C, Geisen C, Mehlhorn U, Diefenbach C. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses. Anesthesiology 2003;99:42-7 (Pubitemid 36799031)
56. Gandhi SD, Weiskopf RB, Jungheinrich C, Koorn R, Miller D, Shangraw RE, Prough DS, Baus D, Bepperling F, Warltier DC. Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch. Anesthesiology 2007;106:1120
57. Langeron O, Doelberg M, Ang ET, Bonnet F, Capdevila X, Coriat P. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg 2001;92:855-62 (Pubitemid 32239122)
58. Ahn HJ, Yang M, Gwak MS, Koo MS, Bang SR, Kim GS, Lee SK. Coagulation and biochemical effects of balanced salt-based high molecular weight vs saline-based low molecular weight hydroxyethyl starch solutions during the anhepatic period of liver transplantation. Anaesthesia 2008;63:235-42 (Pubitemid 351257785)
59. Sander O, Reinhart K, Meier-Hellmann A. Equivalence of hydroxyethyl starch HES 130/0.4 and HES 200/0.5 for perioperative volume replacement in major gynaecological surgery. Acta Anaesthesiol Scand 2003;47:1151-8 (Pubitemid 37108508)
60. Gallandat Huet RC, Siemons AW, Baus D, van Rooyen-Butijn WT, Haagenaars JA, van Oeveren W, Bepperling F. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anaesth 2000;47:1207-15 (Pubitemid 32098997)
61. Jungheinrich C, Sauermann W, Bepperling F, Vogt NH. Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4 (6%) with an optimised in vivo molecular weight in orthopaedic surgery: a randomised, double-blind study. Drugs R D 2004;5:1-9 (Pubitemid 38195419)
62. Mehta Y, Dhar A, Sujatha, Meharwal ZS, Trehan N. Comparison of new HES (130/0.4) and HES (200/0.5) in OPCAB surgery. J Anaesthesiol Clin Pharmacol 2007;23:273-8 (Pubitemid 350291524)
63. Ellger B, Freyhoff J, Van Aken H, Booke M, Marcus MAE. High-dose volume replacement using HES 130/0.4 during major surgery: impact on coagulation and incidence of postoperative itching. Nederlands Tijdschrift Anesthesiol 2006:63-8 (Pubitemid 44408614)
64. Boldt J, Lehmann A, Rompert R, Haisch G, Isgro F. Volume therapy with a new hydroxyethyl starch solution in cardiac surgical patients before cardiopulmonary bypass. J Cardiotho-rac Vasc Anesth 2000;14:264-8 (Pubitemid 30415923)
65. Haynes RB, McKibbon KA, Wilczynski NL, Walter SD, Werre SR. Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: analytical survey. BMJ 2005;330:1179